Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis

Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis

Aims: The effect of the angiotensin receptor–neprilysin inhibitor (ARNI) sacubitril-valsartan in patients with heart failure with preserved ejection fraction (HFpEF) remains unclear, and data on ARNI treatment in peritoneal dialysis (PD) patients are lacking. The present study was designed to assess...

Full description

Bibliographic Details
Main Authors: Sha Fu, Zhenjian Xu, Baojuan Lin, Junzhe Chen, Qiuyan Huang, Yanchun Xu, Anping Xu, Yangxin Chen, Ying Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Medicine
Subjects:
sacubitril-valsartan
heart failure
preserved ejection fraction
peritoneal dialysis
NT-ProBNP
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.657067/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.657067/full

Similar Items